Business Context and Reporting Period
This Form 8-K is a current report filed by Frequency Therapeutics, Inc. (not Korro Bio, Inc., as indicated in the metadata) on May 10, 2023, covering an event that occurred on May 5, 2023. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol FREQ.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Board Resignation: Joel S. Marcus resigned from the Company's Board of Directors and all associated committees.
- Effective Date: The resignation was immediately effective as of May 5, 2023.
- Reason for Departure: The filing explicitly states the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Marcus's departure.
- Confirm whether the Company intends to appoint a replacement director and the timeline for such an appointment.
- Review recent press releases or other filings to ensure no undisclosed disagreements or operational issues exist despite the filing's statement.